Viewing Study NCT04287894


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2025-12-27 @ 10:51 PM
Study NCT ID: NCT04287894
Status: TERMINATED
Last Update Posted: 2024-11-06
First Post: 2019-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module